See update below regarding IV fluids from NJAASC Vice President Cori Prisco

Baxter has reported that the production rooms have been deep cleaned, and equipment assessments, repairs, and testing are underway. Additionally, a second temporary bridge is being installed, with an expected completion in early November. The timeline for resuming production remains unchanged, with operations anticipated to restart in phases by the end of the year.

To boost inventory, seven global plants have been activated, and the FDA has approved temporary imports from Canada, China, Ireland, the UK, Mexico, and Spain. The first shipments arrived last weekend, with more details on product availability and disbursements coming soon.

Stay in close contact with your distributors and sales reps to ensure proper allocation calculations and keep track of your ordering schedules.

Cori Prisco
NJAASC Vice President